M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

76 deals · US$54bndisclosed · Life Sciences · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Mar 2026 JSR Life Sciences chromatography business JSR Life SciencesMERCK KGaAAsset saleCompleted–Life Sciences+1 William Blair
Feb 2026 Bruder Consulting & Venture Group –Dark Horse Consulting GroupAcquisitionCompleted–Accounting, legal and consulting+1 Goodwin (sell-side)Edgemont Partners (sell-side)
Feb 2026 Laysan Bio –Gannet BioChemAcquisitionAnnounced–Pharma Services+2 Goodwin (buy-side)
Feb 2026 Dutscher Group –Vivo CapitalAcquisitionAnnounced–Life Sciences+1 Sidley Austin (buy-side)Mayer Brown (buy-side)
Jan 2026 Ganymede –Apprentice.ioAcquisitionAnnounced–Software+1 Cooley (buy-side)
Jan 2026 StarLIMS –Turn/River CapitalStakeAnnounced–Software+2
Jan 2026 Cannatrek –Little Green PharmaSchemeCompleted–Healthcare+1 K&L Gates (sell-side)Intrinsic Partners (sell-side)RSM (sell-side)Hamilton Locke (buy-side)Canaccord Genuity (buy-side)
Jan 2026 Verana Health ––MergerAnnounced–Healthcare Software+2 BofA Securities (sell-side)Wilson Sonsini Goodrich & Rosati (buy-side)
Jan 2026 Aktana –PharmaForceIQAsset saleAnnounced–Healthcare Software+2 Canaccord Genuity
Jan 2026 PTC Therapeutics' remaining royalty on Roche's Evrysdi PTC TherapeuticsRoyalty PharmaAsset saleAnnounced240.0Specialty finance and leasing+2 Goodwin (buy-side)
Jan 2026 Evidinno Outcomes Research –United BioSourceAcquisitionCompleted–Pharma Services+2 Fairmount Partners (sell-side)
Jan 2026 BioRender –Dimension CapitalStakeAnnounced900.0Software+2 Sidley Austin (sell-side)
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 Freenome Holdings –Perceptive Capital Solutions CorpMergerCompleted725.0Diagnostics+2 TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)
Oct 2025 Sedarex –BiotronAcquisitionCompleted1.0Healthcare+1 Peak Asset Management (buy-side)
Oct 2025 SWK Holdings –Runway Growth Finance Corp.AcquisitionCompleted249.0Financial Services+1 Keefe, Bruyette & Woods (sell-side)Goodwin (sell-side)Kroll (sell-side)Simpson Thacher & Bartlett (buy-side)Dechert (buy-side)
Aug 2025 DBG Global Enterprises –BDT & MSD PartnersStakeAnnounced1,039.4Healthcare+1 MinterEllison (sell-side)
Aug 2025 DBG Health –BDT & MSD PartnersStakeCompleted1,039.4Healthcare+1 MinterEllison (sell-side)Allens (buy-side)Sidley Austin (buy-side)
Jul 2025 BD Biosciences & Diagnostic Solutions business Becton, Dickinson and CompanyWatersAsset saleCompleted18,800.0Life Sciences+2 Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side)
Jun 2025 InVetro –Animalcare GroupStakeAnnounced–Healthcare+1 Squire Patton Boggs (buy-side)
Feb 2025 Mayne Pharma Group –Cosette PharmaceuticalsSchemeWithdrawn417.9Healthcare+1 Jefferies (sell-side)Gilbert + Tobin (sell-side)Arnold & Porter (sell-side)Davis Wright Tremaine (sell-side)EY (sell-side)Deloitte (sell-side)Santander (buy-side)UBS (buy-side)Corrs Chambers Westgarth (buy-side)Ropes & Gray (buy-side)
Feb 2025 AdvanCell –SV Health InvestorsStakeCompleted–Healthcare+1 Johnson Winter Slattery (buy-side)Honigman (buy-side)
Jan 2025 ImaginAb therapeutic candidates, biologics technology platform and research facility ImaginAbTelix PharmaceuticalsAsset saleCompleted45.0Healthcare+1 Jefferies (sell-side)Stifel (sell-side)
Dec 2024 Randlab Group –Animalcare GroupAcquisitionCompleted74.3Healthcare+1 Squire Patton Boggs (buy-side)Pitcher Partners (buy-side)
Apr 2024 Model N –Vista Equity PartnersAcquisitionCompleted1,250.0Vertical SaaS+1 Jefferies (sell-side)Fenwick & West (sell-side)Kirkland & Ellis (buy-side)William Blair (buy-side)
– Northpharm –FortitudeAcquisitionAnnounced–Healthcare+1 KPMG (sell-side)

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.